Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 13Lung Neoplasms 9Carcinoma, Renal Cell 7Rectal Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Esophageal Neoplasms 4Breast Neoplasms, Male 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Kidney Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Brain Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Spinal Cord Neoplasms 2

Interventions

fluoromisonidazole 1Taxes 1Radiation 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stage III Lung Non-Small Cell Cancer AJCC v7 × Fluorodeoxyglucose F18 × Clear all
NCT01507428 2026-04-21

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
138 enrolled 42 charts

Stage III Lung Non-Small Cell Cancer AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡